Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 469 of 5804
-
Could a Pre-Surgery immune booster beat standard care for skin cancer?
Disease control TerminatedThis phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may hav…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control OngoingThis is a single-center, open-label, single-arm, dose-escalation study aimed at evaluating the safety and preliminary efficacy of KRAS-specific autologous TCR-T cells in patients with advanced solid tumors harboring KRAS G12V mutation.
Phase: PHASE1 • Sponsor: Corregene Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Hormone combo could boost diabetes control in menopause
Disease control Recruiting nowThe overall aim is to investigate the hypothesis that restoring E2 levels through MHT improves glucose and energy homeostasis and potentiates the beneficial effects of GLP-1RA in early postmenopausal women with pre- or existing type 2 diabetes. The primary objective is to assess…
Phase: NA • Sponsor: Lia Bally • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug cocktail aims to supercharge weight loss
Disease control CompletedThe purpose of this study is to determine whether treatment with AZD9550 when given in combination with AZD6234 as once weekly subcutaneous (SC) injections is superior to placebo or either agent administered as monotherapy for weight loss in participants living with obesity or ov…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Customized grafts could repair dangerous aortic aneurysms without open surgery
Disease control Recruiting nowThe primary objective of the clinical investigation "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms" is to assess the use of the Physician-Modified Endovascular Grafts to repair juxtarenal aneurysms in hig…
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Tailored radiation boosts survival in lung cancer trial
Disease control Recruiting nowThis is a Phase II/III randomized clinical trial of Radiosensitivity-Assisted Personalized Adaptive Radiotherapy Technology (RAPART) in locally advanced non-small cell lung cancer patients. The main objective is to test the overall improvement of overall survival (OS), progressio…
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
AI-Powered pocket microscope could revolutionize esophageal cancer detection
Diagnosis Recruiting nowIn a previous clinical trial in China and the United States (US), the investigators developed and validated a mobile, high-resolution microendoscope (mHRME) for screening and surveillance of esophageal squamous cell neoplasia (ESCN). The trial revealed higher specificity for qual…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New hope for rare cervical cancer: Triple-Drug trial launches
Disease control Recruiting nowGastric-type adenocarcinoma of the cervix is the most commonly diagnosed HPV-independent subtype of cervical cancer, characterized by a poor prognosis and limited responsiveness to existing therapies. Therefore, the exploration of new treatment modalities is critically important.…
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could metformin or colchicine ease long COVID? major trial launches
Disease control ENROLLING_BY_INVITATIONRECLAIM is a Phase III, multi-domain, randomized, controlled, adaptive platform trial, designed to evaluate efficacy and safety of repurposed medications in patients with post-COVID condition (PCC). The trial started in the Netherlands in February 2025, comparing metformin, colch…
Phase: PHASE3 • Sponsor: Janneke van de Wijgert • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for prostate cancer: drug combo before surgery shows promise
Disease control OngoingA Randomized Trial of Neoadjuvant Leuprorelin, Darolutamide or Both Prior to Radical Prostatectomy for Intermediate or High-risk Prostate Cancer. Prospective, randomized, parallel group, open-label with blinded endpoint adjudication multicenter clinical trial.To assess, among pat…
Phase: PHASE4 • Sponsor: Brazilian Clinical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a gum infection drug slow Alzheimer's? new trial launches
Disease control Recruiting nowThis study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis (Pg) infection. P. gingivalis infection has been linked to the development of dementia. LHP588 is desig…
Phase: PHASE2 • Sponsor: Lighthouse Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Triple-Drug attack before prostate surgery shows promise in early trial
Disease control Recruiting nowThe high incidence of prostate cancer is one of the important diseases that threaten the health of old men in our country. Although androgen deprivation therapy is an important treatment option for prostate cancer, although neoadjuvant androgen deprivation therapy combined with r…
Phase: PHASE2, PHASE3 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New shingles vaccine trial aims to protect millions over 40
⭐️ VACCINE ⭐️ OngoingThe objective of this study was to evaluate the safety, immunogenicity and immune persistence of recombinant herpes zoster vaccine (CHO cells) with different adjuvant doses in healthy people aged 40 years and older.
Phase: PHASE1, PHASE2 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:01 UTC
-
New combo aims to boost lung cancer treatment in patients with bone metastases
Disease control Recruiting nowIntroduction: Immunotherapy in combination with chemotherapy have been recommended as the first-line treatment of driver-negative advanced non-small cell lung cancer (NSCLC), but the efficacy is worse in NSCLC patients with bone metastases due to the immunosuppressive microenviro…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Heart surgery patients may get a patch to stop dangerous rhythm problems
Prevention Recruiting nowThe primary objective of the present prospective, randomized, double blind, controlled study is to assess whether the application of 2 oxidized regenerated cellulose (SurgicelTM FibrillarTM) patches soaked with amiodarone hydrochloride over the anterior wall of the left atrium an…
Phase: PHASE3 • Sponsor: Jilin Heart Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Gene therapy hope for kids with rare muscle-wasting disease
Disease control OngoingThe purpose of ATA-003-GSAR study is to evaluate the safety and tolerability of a single intravenous infusion of ATA-200 in pediatric patients with limb girdle muscular dystrophy type 2c/R5 (LGMD R5).
Phase: PHASE1 • Sponsor: Atamyo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug cocktail aims to fight kidney cancer when immunotherapy fails
Disease control Recruiting nowThe researchers are doing this study to find out whether the combination of abemaciclib and cabozantinib is a safe and effective treatment for people with metastatic clear cell renal cell carcinoma (ccRCC) and translocation-associated renal cell cancer (tRCC). The researchers wil…
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New Worm-Fighting pill could help millions of children
Disease control Recruiting nowThis is a Phase 3, multi-center, prospective, randomized, double-blind, placebo-controlled study to evaluate the effectiveness, safety, and tolerability of ZP5-9676 compared to placebo for the treatment of STH infections. Approximately 300 participants will be enrolled, randomize…
Phase: PHASE3 • Sponsor: Zero Point Five Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New combo attack on rare eye cancer shows promise in early trial
Disease control Recruiting nowThe purpose of this study is to determine the effects (good and bad) that Tebentafusp in combination with Yttrium-90 (Y-90) radioembolization has on patients with metastatic uveal melanoma that has spread to the liver.
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a weekly shot help tame type 1 diabetes?
Disease control Recruiting nowBlood glucose management in type 1 diabetes (T1D) remains a challenge, with only \~30% of adults within the recommended consensus guidelines. Novel drugs like glucagon-like peptide-1 receptor agonists (GLP-1RAs) and glucose-dependent insulinotropic polypeptide (GIP)/GLP-1RAs have…
Phase: PHASE3 • Sponsor: University of Bern • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC